Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2012
03/07/2012EP2424882A2 Peptides protective against e. faecalis, methods and uses relating thereto
03/07/2012EP2424566A2 Dual variable domain immunoglobulins and uses thereof
03/07/2012EP1961767B1 Diagnosis and treatment of cancers and other conditions
03/07/2012EP1773884B1 Therapeutic and diagnostic methods and compositions targeting 4ig-b7-h3 and its counterpart nk cell receptor
03/07/2012EP1730197B1 Methods for inducing autolysis in infectious bacteria
03/07/2012EP1713907B1 Hybrid proteins of active-site serine beta-lactamase.
03/07/2012EP1692184B1 Antibodies that bind interleukin-4 receptor
03/07/2012CN102369291A Stabilized Fc polypeptides with reduced effector function and methods of use
03/07/2012CN102369285A Beta-gi-igg intron for enhanced anti-igf1 r expression
03/07/2012CN102369219A Antibodies against human tweak and uses thereof
03/07/2012CN102369218A Anti-fcrh5 antibodies and immunoconjugates and methods of use
03/07/2012CN102369217A Il-1 binding proteins
03/07/2012CN102369216A Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same
03/07/2012CN102369215A Multispecific antibodies comprising full length antibodies and single chain fab fragments
03/07/2012CN102369214A Trivalent, bispecific antibodies
03/07/2012CN102367436A Anti-human spermine oxidase monoclonal antibody and application thereof
03/07/2012CN101495536B Methods for site-specific pegylation
03/06/2012US8129517 Labeled solid supports for organic synthesis
03/06/2012US8129508 Protein purification using HCIC and ion exchange chromatography
03/06/2012US8129507 Atopic dermatitis inducer
03/06/2012US8129506 Modulation of the interaction of MUC1 with MUC1 ligands
03/06/2012US8129505 Comb polymers
03/06/2012US8129503 Agents that bind a target in pulmonary tissue for targeting respiratory diseases
03/06/2012US8129502 Monoclonal antibody produced by hybridoma with IDAC accession number 180706-02; competitive binding of monoclonal antibody, humanized-, chimeric- or cancerous disease modifying antibodies (CDMAB) with tissue sample induces cytotoxicity; anticarcinogenic, antitumor, and antimetastasis agents; diagnosis
03/06/2012US8129331 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT
03/06/2012US8129167 UL16 binding protein 4
03/06/2012US8129129 Method for diagnosing tumors
03/06/2012US8128963 Methods for treating ischemic disorders using carbon monoxide
03/06/2012US8128938 Influenza virus vaccine composition and methods of use
03/06/2012US8128934 Method for treatment or prevention of disease associated with functional disorder of regulatory T cell
03/06/2012US8128932 Anti-VEGFR monoclonal antibody, method of making and uses thereof
03/06/2012US8128930 Anti-ADDL antibodies and uses thereof
03/06/2012US8128928 Humanized antibodies that recognize beta amyloid peptide
03/06/2012US8128926 Sp35 antibodies and uses thereof
03/06/2012CA2593122C Anti a beta antibody formulation
03/06/2012CA2470579C Production of f(ab')2 fragments in mammalian cells
03/06/2012CA2445664C Use of il-18 inhibitors for treating or preventing cns injuries
03/06/2012CA2423979C Method for quantifying phosphokinase activity on proteins
03/06/2012CA2290944C Pgc-1, a novel brown fat ppar.gamma. coactivator
03/06/2012CA2202408C Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
03/01/2012WO2012027723A1 Notum protein modulators and methods of use
03/01/2012WO2012027677A1 Methods and compositions for prediction of bone fracture in subjects with kidney disease
03/01/2012WO2012027570A2 Dual variable domain immunoglobulins and uses thereof
03/01/2012WO2012027494A1 Bispecific targeting reagents
03/01/2012WO2012027440A1 Hiv core protein specific antibodies and uses thereof
03/01/2012WO2012027328A2 Anti-ox40 antibodies and methods of using the same
03/01/2012WO2012026878A1 Monoclonal antibody specific to major neutralizing epitope of influenza h5 hemagglutinin
03/01/2012WO2012026615A1 Method for producing antibodies using cancer cells
03/01/2012WO2012026526A1 Hemokinin-1 receptor and hemokinin-1-derived peptide
03/01/2012WO2012026339A1 Ice crystallization inhibitor derived from basidiomycetes
03/01/2012WO2012026309A1 Creation of anti-pad4 antibody pharmaceutical
03/01/2012WO2012025621A1 Compositions for seed treatment
03/01/2012WO2012025619A1 Chitinous polysaccharide antigen binding proteins
03/01/2012WO2012025602A1 Insect binding antibodies
03/01/2012WO2012025536A1 Antibodies against il-18r1 and uses thereof
03/01/2012WO2012025530A1 Bispecific antibodies comprising a disulfide stabilized - fv fragment
03/01/2012WO2012025525A1 Activatable bispecific antibodies
03/01/2012WO2011158122A3 Anti-human equilibrative nucleoside transporter 1 (hent1) antibodies and methods of use thereof
03/01/2012WO2011156617A3 Anti-egfr antibodies
03/01/2012WO2011145085A3 Novel antibodies and methods of use for the treatment and diagnosis of cancer
03/01/2012WO2011143562A3 Il-1 binding proteins
03/01/2012WO2011106100A3 Method of inducing the production of protective anti-hiv-1 antibodies
03/01/2012WO2011098518A3 Delivery of immunoglobulin variable domains and constructs thereof
03/01/2012WO2011096698A9 Composition for cancer prognosis prediction comprising anti-tmap/ckap2 antibodies
03/01/2012US20120053326 Agonist antibody to human thrombopoietin receptor
03/01/2012US20120053325 Purification of Immunoglobulins
03/01/2012US20120053321 Zcytor19 heterodimeric cytokine receptor polynucleotides, polypeptides, antibodies and methods
03/01/2012US20120053232 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN TUMOR SUPPRESSING SUBTRANSFERABLE CANDIDATE 4 (TSSC4)
03/01/2012US20120053225 Akt tyrosine 176 phosphorylation cancer biomarker
03/01/2012US20120053125 Phosphatase inhibitor protein-1 as a regulator of cardiac function
03/01/2012US20120053079 Methods and compositions for the diagnosis, prognosis and treatment of cancer
03/01/2012US20120052596 Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same
03/01/2012US20120052592 Method for determining prognosis of acute central nervous system disorder
03/01/2012US20120052569 Tag peptide having a protease recognition sequence and use thereof
03/01/2012US20120052566 Anti-vegf-c antibodies and methods using same
03/01/2012US20120052515 Therapeutic applications of noncovalent dimerizing antibodies
03/01/2012US20120052513 Gold sub-nanoclusters and uses thereof
03/01/2012US20120052110 Methods and compositions for promoting wound healing
03/01/2012US20120052087 Siderophore Conjugate Immunogenic Compositions and Vaccines
03/01/2012US20120052084 Staphylococcus aureus proteins and nucleic acids
03/01/2012US20120052079 Compositions, Kits, and Methods for Predicting Anti-Cancer Response to Anthracyclines
03/01/2012US20120052076 Anti-trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors
03/01/2012US20120052073 Antibodies Directed to Angiopoietin-2 And Uses Thereof
03/01/2012US20120052071 Tumor markers and methods of use thereof
03/01/2012US20120052068 Autophilic antibodies and method of making the same
03/01/2012US20120052060 Human Antibody Molecules For IL-13
03/01/2012US20120052044 Uses of mammalian cytokine; related reagents
03/01/2012US20120052007 Peripheral blood sparc binding antibodies and uses thereof
03/01/2012CA2809433A1 Dual variable domain immunoglobulins and uses thereof
03/01/2012CA2809369A1 Notum protein modulators and methods of use
03/01/2012CA2809363A1 Hiv core protein specific antibodies and uses thereof
03/01/2012CA2809218A1 Compositions for seed treatment
03/01/2012CA2809089A1 Anti-ox40 antibodies and methods of using the same
03/01/2012CA2808539A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases
03/01/2012CA2808418A1 Antibodies to matrix metalloproteinase 9
03/01/2012CA2807278A1 Bispecific antibodies comprising a disulfide stabilized - fv fragment
03/01/2012CA2807269A1 Activatable bispecific antibodies
03/01/2012CA2805054A1 Antibodies against il-18r1 and uses thereof
02/2012
02/29/2012EP2423685A1 Agent and method for diagnosis on the occurrence of Alzheimer's disease
02/29/2012EP2423321A2 Use of HE4 and other biochemical markers for assessment of endometrial and uterine cancers
1 ... 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 ... 1494